Research Appraisals
Evidence-based critical appraisals of the latest medical research, systematically evaluated using Oxford CEBM methodology.
Showing 5 appraisals
Journal of chemical information and modeling
Machine Learning for RNA-Targeting Drug Design
Targeting RNA with small molecules offers significant therapeutic potential. Machine learning could substantially accelerate preclinical drug discovery, from hit identification to lead optimization. Yet a limitation emerges: drug design machine learning models, designed for proteins, are not readily applicable to RNAs because of fundamental differences between RNAs and proteins in both structural characteristics and interactions with small molecules. RNA-specific approaches have consequently emerged, primarily focusing on binding site identification and virtual screening. In this review, we comprehensively compare machine learning tools for RNA-targeting drug design according to the tasks they address, their methodology and their relevance in RNA-specific contexts. As open challenges will catalyze new method development, we emphasize the need for standardized, drug design-specific evaluation approaches. We provide clear guidelines to establish these standards and present a benchmark assessing the ability of current machine learning models to predict specific drug-RNA interactions.
28 July 2026
Read appraisal →Cell
Deep learning of functional perturbations from condensate morphology
Biomolecular condensates compartmentalize the interior of cells to organize complex functions, yet linking molecular interactions within condensates to their mesoscale organization remains a major challenge. To bridge this gap, we developed a neural-network-based framework-Deep-Phase (deep learning of phase-separated condensates)-that uses microscopy images to directly measure condensate morphology changes resulting from pharmacological alterations in associated biochemical processes. We use Deep-Phase to precisely quantify time- and concentration-dependent structural perturbations to the multiphase nucleolus and show that they are tightly coupled to potencies of drugs inhibiting ribosomal RNA (rRNA) transcription and processing. Applying Deep-Phase in a chemical screen, we identify a unique nucleolar morphology and discover a role for a DNA topoisomerase in rRNA processing. Mechanistic studies of this morphology provide insights into how the interfaces between nucleolar sub-compartments are maintained. We demonstrate Deep-Phase's adaptability to diverse cell lines, labeling techniques, and condensates, offering a powerful platform for connecting molecular pathways to cellular mesoscale organization.
25 July 2026
Read appraisal →ACS infectious diseases
Machine Learning Approaches Using High-Throughput Profiling Data for Antibiotic Discovery
Antibiotic-resistant bacterial infections continue to increase globally, creating an urgent need for new antibacterials with novel mechanisms of action. Early stages of antibiotic discovery are often limited by the difficulty of identifying compounds that act through previously unrecognized pathways and by challenges in determining their mechanisms. Machine learning (ML) integrated with high-throughput profiling now provides systematic approaches to overcome these barriers. Beyond initial hit discovery, multilayer profiling using morphological phenotyping, transposon sequencing, transcriptomics, proteomics, and metabolomics captures cellular responses that reflect the mechanisms of action. Because profiling data sets are typically high-dimensional and contain defined features and variables, ML can extract complex patterns associated with pathway-level responses and predict mechanisms for unknown compounds. In this review, we summarize current progress in high-throughput profiling and describe how ML applied to each data set can accelerate the identification of antibacterials with new mechanisms. These approaches accelerate the transition from large-scale compound screening to mechanistic validation and enable effective prioritization of lead compounds in early-stage antibiotic discovery.
11 July 2026
Read appraisal →Briefings in bioinformatics
EssTFNet: integration of adaptive time-frequency and DNA language models for interpretable human essential gene prediction
Essential genes are defined as indispensable for an organism's survival. The loss of function of these genes results in cell death or an inability to complete the normal life cycle. Research on essential genes is pivotal in elucidating the origin and evolution of life, as well as in identifying potential therapeutic targets. Therefore, predicting essential genes is of great scientific importance and has many applications in basic research and the biomedical field. In this study, we propose EssTFNet, a novel, interpretable deep learning framework that combines adaptive time-frequency analysis with a DNA language model to achieve accurate prediction of human essential genes while enabling mechanistic biological interpretation. EssTFNet leverages the architecture of ATFNet, which maps DNA and protein sequences into equivalent time-series signals to extract periodic and nonstationary features, enhancing the model's capacity to capture complex sequence patterns. Through feature selection and architectural optimization, EssTFNet achieves a favorable balance among prediction accuracy, model interpretability, and cross-tissue generalization. On the S1 benchmark task, EssTFNet outperformed mainstream sequence-based deep learning methods, achieving an area under the curve of 0.9679 and an area under the precision-recall curve of 0.8491. Additionally, the DeepLIFT attribution method was employed to identify functional motifs associated with gene essentiality, offering valuable insights for experimental validation. For the convenience of researchers, we have developed an easy-to-use web server and made it along with the source code in a GitHub repository: https://github.com/QIANJINYDX/EssTFNet. Overall, this study presents a potentially useful methodological framework for human essential genes prediction, which could provide valuable insights for future research and applications in this field.
5 July 2026
Read appraisal →Journal of chemical information and modeling
BioTD: An Online Database of Biotoxins
Biotoxins, mainly produced by venomous animals, plants, and microorganisms, exhibit high physiological activity and unique effects such as lowering blood pressure and analgesia. A number of venom-derived drugs are already available on the market, with many more candidates currently undergoing clinical and laboratory studies. However, drug design resources related to biotoxins are insufficient, particularly because of a lack of accurate and extensive activity data. To fulfill this demand, we developed the Biotoxins Database (BioTD). BioTD is the largest open-source database for toxins, offering open access to 14,607 data records (8,185 activity records), covering 8,975 toxins sourced from 5,220 references and patents across over 900 species. The activity data in BioTD are categorized into five groups: Activity, Safety, Kinetics, Hemolysis, and other physiological indicators. Moreover, BioTD provides data on 1,532 mutants, refines the whole sequence and signal peptide sequences of toxins, and annotates disulfide-bond information. All of the data in the database can be downloaded for free. Given the importance of biotoxins and their associated data, this new database is expected to attract broad interest from diverse research fields in drug discovery. BioTD is freely accessible at http://biotoxin.net/.
23 June 2026
Read appraisal →